Consumer products behemoth Proctor & Gamble (NYSE: PG) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.4% year on year to $21.24 billion. Its non-GAAP profit of $1.59 per share was 2.2% above analysts’ consensus estimates.
Is now the time to buy Procter & Gamble? Find out by accessing our full research report, it’s free.
Procter & Gamble (PG) Q1 CY2026 Highlights:
- Revenue: $21.24 billion vs analyst estimates of $20.52 billion (7.4% year-on-year growth, 3.5% beat)
- Adjusted EPS: $1.59 vs analyst estimates of $1.56 (2.2% beat)
- Adjusted EBITDA: $5.49 billion vs analyst estimates of $5.46 billion (25.9% margin, 0.5% beat)
- Management reiterated its full-year Adjusted EPS guidance of $6.96 at the midpoint
- Operating Margin: 21.5%, down from 23.3% in the same quarter last year
- Free Cash Flow Margin: 14.3%, similar to the same quarter last year
- Organic Revenue rose 3% year on year
- Sales Volumes rose 2% year on year (-1% in the same quarter last year)
- Market Capitalization: $338.6 billion
Company Overview
Founded by candle maker William Procter and soap maker James Gamble, Proctor & Gamble (NYSE: PG) is a consumer products behemoth whose product portfolio spans everything from facial tissues to laundry detergent to feminine care to men’s grooming.
Revenue Growth
Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.
With $86.72 billion in revenue over the past 12 months, Procter & Gamble is one of the most widely recognized consumer staples companies. Its influence over consumers gives it negotiating leverage with distributors, enabling it to pick and choose where it sells its products (a luxury many don’t have). However, its scale is a double-edged sword because there are only so many big store chains to sell into, making it harder to find incremental growth. To accelerate sales, Procter & Gamble likely needs to optimize its pricing or lean into new products and international expansion.
As you can see below, Procter & Gamble’s sales grew at a sluggish 2.3% compounded annual growth rate over the last three years, but to its credit, consumers bought more of its products.
This quarter, Procter & Gamble reported year-on-year revenue growth of 7.4%, and its $21.24 billion of revenue exceeded Wall Street’s estimates by 3.5%.
Looking ahead, sell-side analysts expect revenue to grow 1.6% over the next 12 months, similar to its three-year rate. This projection doesn't excite us and indicates its newer products will not catalyze better top-line performance yet.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
Volume Growth
Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.
Procter & Gamble’s quarterly sales volumes have, on average, stayed about the same over the last two years. This stability is normal because the quantity demanded for consumer staples products typically doesn’t see much volatility. 
In Procter & Gamble’s Q1 2026, sales volumes jumped 2% year on year. This result was an acceleration from its historical levels, certainly a positive signal.
Key Takeaways from Procter & Gamble’s Q1 Results
We enjoyed seeing Procter & Gamble beat analysts’ revenue expectations this quarter on positive volume growth. EPS also beat, and the company reaffirmed full-year EPS guidance, showing that the business is on track. On the other hand, its gross margin missed. Overall, this print had some key positives. The stock traded up 2.6% to $149.47 immediately after reporting.
Should you buy the stock or not? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).
